DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS

Clinical trials for DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS explained in plain language.

Never miss a new study

Get alerted when new DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS trials appear

Sign up with your email to follow new studies for DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 2 Not yet finished but already full! 3 Completed 1 Terminated 2

New drug tested to fight hardening skin and lung damage in severe scleroderma

Disease control Completed

This study tested an investigational drug called MT-7117 to see if it could improve the condition of people with diffuse cutaneous systemic sclerosis, a severe form of scleroderma. For one year, 76 participants with active, early-stage disease received either the drug or a placeb…

Matched conditions: DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS

Phase: PHASE2 • Sponsor: Tanabe Pharma America, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS

Get alerted when new DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS trials appear

New drug tested to fight hardening skin and lung damage in severe scleroderma